CXCR2 immunomodulatory therapy protects against microstructural white matter injury and gait abnormalities but does not mitigate deficits of cognition in a preclinical model of cerebral palsy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yuma Kitase, Nethra K. Madurai, Rachel J. Boyd, Gwendolyn Gerner, Adnan Bibic, Andrew S. McCallion, Eric M. Chin, Shenandoah Robinson, Lauren L. Jantzie
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Neurochemistry
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet